Jefferies Group LLC reiterated their hold rating on shares of Analogic Corporation (NASDAQ:ALOG) in a research report released on Wednesday. Jefferies Group LLC currently has a $75.00 price target on the medical research company’s stock. Jefferies Group also issued estimates for Analogic Corporation’s Q1 2018 earnings at $0.38 EPS, Q2 2018 earnings at $0.69 EPS, Q3 2018 earnings at $1.00 EPS, Q4 2018 earnings at $0.74 EPS, FY2018 earnings at $2.80 EPS, FY2019 earnings at $2.94 EPS, FY2020 earnings at $3.18 EPS, FY2021 earnings at $3.32 EPS and FY2022 earnings at $3.49 EPS.

Shares of Analogic Corporation (NASDAQ ALOG) opened at 81.15 on Wednesday. The company’s 50-day moving average price is $71.91 and its 200 day moving average price is $72.12. The company’s market cap is $1.01 billion. Analogic Corporation has a 1-year low of $66.00 and a 1-year high of $95.85.

TRADEMARK VIOLATION WARNING: This story was first posted by Daily Political and is the sole property of of Daily Political. If you are reading this story on another site, it was stolen and reposted in violation of United States and international trademark & copyright law. The original version of this story can be viewed at https://www.dailypolitical.com/2017/09/23/jefferies-group-llc-reaffirms-hold-rating-for-analogic-corporation-alog.html.

The company also recently announced a quarterly dividend, which will be paid on Friday, October 13th. Investors of record on Friday, September 29th will be issued a $0.10 dividend. This represents a $0.40 annualized dividend and a yield of 0.49%. The ex-dividend date of this dividend is Thursday, September 28th. Analogic Corporation’s dividend payout ratio is currently -6.70%.

Institutional investors have recently modified their holdings of the stock. SG Americas Securities LLC bought a new position in Analogic Corporation in the 1st quarter worth $101,000. US Bancorp DE boosted its holdings in Analogic Corporation by 59.0% in the 1st quarter. US Bancorp DE now owns 1,635 shares of the medical research company’s stock worth $124,000 after buying an additional 607 shares during the period. Flinton Capital Management LLC boosted its holdings in Analogic Corporation by 100.0% in the 2nd quarter. Flinton Capital Management LLC now owns 1,768 shares of the medical research company’s stock worth $129,000 after buying an additional 884 shares during the period. State of Alaska Department of Revenue boosted its holdings in Analogic Corporation by 78.9% in the 2nd quarter. State of Alaska Department of Revenue now owns 2,469 shares of the medical research company’s stock worth $179,000 after buying an additional 1,089 shares during the period. Finally, Dubuque Bank & Trust Co. boosted its holdings in Analogic Corporation by 8.8% in the 2nd quarter. Dubuque Bank & Trust Co. now owns 2,651 shares of the medical research company’s stock worth $193,000 after buying an additional 215 shares during the period. 98.91% of the stock is owned by institutional investors.

Analogic Corporation Company Profile

Analogic Corporation designs, manufactures and commercializes guidance, diagnostic imaging and threat detection technologies. The Company operates through three segments: Medical Imaging, Ultrasound, and Security and Detection. The Company’s Medical Imaging segment provides medical imaging systems and subsystems for computed tomography (CT), magnetic resonance imaging (MRI) and high-resolution digital mammography.

Receive News & Ratings for Analogic Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Analogic Corporation and related companies with MarketBeat.com's FREE daily email newsletter.